X4 Pharmaceuticals, Inc. (XFOR)

Last Closing Price: 4.03 (2026-08-20)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

X4 Pharmaceuticals, Inc. (XFOR) had Net Income of $-16.16M for the most recently reported fiscal quarter, ending 2026-06-30.

Figures for fiscal quarter ending 2026-06-30
Income Statement Financials
$8.81M
Net Income
$-16.16M
$1.62M
$7.19M
$25.20M
$-16.39M
$0.24M
$-16.16M
$-16.16M
$-16.16M
$-16.16M
$-16.16M
$-16.16M
$-16.39M
$-15.39M
126.34M
126.34M
$-0.13
$-0.13
Balance Sheet Financials
$218.85M
$0.11M
$34.21M
$253.06M
$19.37M
$76.76M
$78.24M
$97.61M
$155.45M
$125.00M
$155.45M
96.11M
Cash Flow Statement Financials
$-40.39M
$18.25M
$0.08M
$217.85M
$195.77M
$-22.08M
$5.50M
--
--
Fundamental Metrics & Ratios
11.30
--
--
0.33
0.49
81.64%
-186.13%
-186.13%
--
-183.45%
-183.48%
$-40.39M
--
--
--
0.03
0.29
4.30
20.92
-10.39%
-12.93%
-6.38%
-6.96%
$1.62
$-0.32
$-0.32